Search results
Results from the WOW.Com Content Network
BofA Securities has upgraded Inspire Medical Systems, Inc. (NYSE:INSP) and says the company now falls in the profitable growth category. Inspire Medical is expected to give its 2025 revenue ...
About Inspire Medical Systems Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that ...
In April 2018, an Inspire data scientist was an author of a Nature Genetics correspondence [16] about ways to close the"terminology gap" between medical professionals and patients. Also in 2018, Inspire collaborated with ProPublica and Memorial Sloan Kettering Cancer Center in research that led to a paper in the Journal of Oncology Practice. [17]
Inspire (INSP) delivered earnings and revenue surprises of 45.07% and 59.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
The medical technology company Inspire Medical Systems, Inc. (NYSE: INSP ) went public Thursday on the New York Stock Exchange. What Happened The company issued 6.75 million shares priced at $16 ...
Inspire Medical Systems, Inc. Health Care Health Care Equipment Golden Valley, Minnesota: view: 0001609550 INVA: Innoviva, Inc. Health Care Pharmaceuticals
These investments include Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, GlycoFi, Transform Pharmaceuticals, and Remon Medical Technologies. Akamai is an internet service that deals with Web interactions, and works to improve effective connections. Today, Akamai is a public company. Another example is GlycoFi, which creates ...
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...